Tim McHugh
Analyst · Steve Sakwa of Evercore ISI
Thank you, Tom. My comments today will focus on our first quarter 2020 results. The early impact of COVID-19 and our tenants observed within the quarter and into April. And finally, a capital activity and balance sheet update. As a reminder to everyone on the call, Welltower removed all components of full year guidance in mid-April, after reviewing our first month of financial results with the impact of COVID-19. We believe the extent of COVID-19's impact on our portfolio will depend on many factors. We cannot accurately predict the future implications this pandemic will have in our business trends at this time. Although, there is no assurance that we are currently experiencing peak impact as it pertains to both our business or the broader economy, we are hopeful that we are moving through the period of peak uncertainty. And as that uncertainty diminishes, we'll be able to provide you more clarity on our outlook. Moving to the quarter, Welltower reported normalized FFO of $1.02 per diluted share for the first quarter. These results included a total of $7 million or approximately $0.02 per diluted share of unanticipated property level costs in our senior housing operating portfolio, associated with the COVID-19 pandemic. Welltower is elected to not normalize these COVID-related expenses from both FFO and same-store results. Now turning to our individual portfolio of components. First, our Seniors Housing Triple-Net portfolio delivered 3% year-over-year same-store growth and both occupancy and EBITDAR coverages were flat on a sequential basis. As a reminder, our Triple-Net lease portfolio operating stats reported a quarter in arrears. So these statistics reflect the trailing 12 months ending 12/31/2019 and therefore do not reflect any impact in COVID-19. We expect our Seniors Housing Triple-Net operators to experience similar headwinds as everyday operators during the second quarter. Next, our long-term post-acute portfolio generated 2.6% year-over-year same-store growth. And EBITDAR coverage declined by three basis points sequentially. On to health systems which is comprised of our joint venture with ProMedica. As indicated on last quarter's call, EBITDAR growth was strong in the fourth quarter in this portfolio and subsequently rent coverage improved eight basis points sequentially to 2.14 times. Rent collection across our Triple-Net segments including seniors housing, long-term post-acute and health systems was consistent with the historical in the first quarter. In April, we have collected 97% of total rents due. Turning to medical office. Our outpatient medical portfolio had another consistent quarter delivering 2.1% same-store growth. Our rent collection was in line with historical norms in the first quarter and in April we collected or approved rent deferral on 95% of our rent due. Early on in the pandemic, we are in active discussions with our tenants that were most impacted by the considerable slowdown in the facilities-based revenue streams, most significantly elected procedures. We focused on providing 60-day deferrals spanning April and May and as a result of these discussions, we've approved approximately 8% of our monthly rents for two-month deferral plans with payback periods within calendar year 2020. As of today, we believe approximately 25% of these deferrals, we brought current in the near term as tenants received financial support and see operations begin to open back up. Lastly, our Seniors Housing operating portfolio year-over-year same-store NOI declined 1.6% in the quarter. A stronger-than-expected first two months of the year were more than offset by the negative impact of COVID-19 on both March occupancy and expenses with approximately 5.2 million of unanticipated expenses occurring in the property level within our same-store pool. As a reminder, we did not normalize COVID-related expenses out of our same-store metrics. Turning to April and as highlighted in our business update presentation released alongside our earnings last night, we experienced an acceleration in the occupancy pressures that began in March, as total portfolio occupancy fell 240 basis points in the month of April versus a 70 basis point decline in March, driven primarily by a significant decrease in move-ins as outright admission bans became more common across our portfolio at the start of April. We expect these occupancy declines to continue throughout the second quarter with occupancy expected to decrease 500 to 600 basis points by June 30th. We intend to continue our periodic updates throughout the second quarter to help investors and analysts better understand these trends. Before turning to the balance sheet, I wanted to make one final point on same-store. As I alluded to last quarter and as shown in this morning's 10-Q, we have aligned our Q and K disclosures of same-store with our supplemental disclosures, but the only difference is being the normalizations that we detail on page 22 of our supplement consistent with historical disclosure practices. Now on to the balance sheet and capital activity. I want to move through these highlights in two distinct sections. First our balance sheet, focusing on both liquidity and leverage; and then capital spend as it pertains to investments, developments, CapEx, corporate overhead and lastly our dividend. Starting with capital market activity. In early March we obtained commitments for a two-year unsecured term loan of $1 billion bearing interest at LIBOR plus 120 with the right to further upsize the borrowed amount by $200 million. We've closed on this loan on April 1st and the loan will be drawn in the second quarter. During the quarter we issued approximately two million shares via our DRIP and ATM forward programs at a weighted average price of $83.94 per share for estimated proceeds of $171 million. At the end of the quarter, we settled these in all prior forward sale agreements totaling 6.8 million shares and average price of $86.48 per share for $588 million of gross proceeds. The settlement of these forwards this brings Welltower's equity raise via DRIP and ATM since the start of 2019 to $1.7 billion at an average price of $80.64. Following these activities and as of May 4, we have approximately $2.36 billion of capacity under our $3 billion unsecured revolving credit facility, $1 billion of capacity under our undrawn term loan and cash and cash equivalents of $348 million, totaling just over $3.7 billion of liquidity with no unsecured debt maturities until 2023. Turning to leverage. We ended the quarter at 5.93 times net debt to adjusted EBITDA, a 44 basis point sequential decrease from year-end. Although, we expect EBITDA to experience more bearing in the coming quarters due to the impact of COVID-19, we believe our leverage position entering this challenging period as well as our liquidity position will allow us to endure this period of uncertainty. Moving to capital spend and starting with investments. In the first quarter, we completed $398 million of acquisitions across four separate transactions at a blended yield of 5.6%. We have no further material acquisitions under contract for the remainder of 2020. On the disposition front, we completed $781 million of pro rata dispositions including $64 million related to a disposition of an unconsolidated equity investment during the quarter. We anticipate another $386 million of property sales during the remainder of the year including $121 million of sales and the final two tranches of our Invesco JV, the first of which closed in April for $74 million. Moving to development, we completed the $141 million of development spend in the quarter. We expect development spend of $463 million for the remainder of the year and then only $178 million of spend beyond 2020 to complete our current pipeline. The large majority of our development pipeline in the final stages of construction, we continue to view these developments as excellent uses of capital and as a medium-term source of natural deleveraging as they begin to produce cash flow over the next 24 months. Turning to capital spend on our existing portfolio. We anticipate reducing our CapEx by approximately $90 million from our initial budget for 2020. This will be accomplished from a combination of tighter restrictions and project work during the pandemic, deferred leasing capital on outpatient medical as leasing activity slows during the same period and also some delaying of larger capital projects across all asset types until we have more certainty around our outlook. Now on to corporate overhead. I first want to start by acknowledging the incredible work done across our organization over the past two months. We've spent considerable time over the last four years, focusing on lowering the run rate costs of managing our business on behalf of shareholders. Our core initiative in this pursuit has been the operational efficiencies gained through streamlining reporting systems. And although we certainly did not have this current pandemic in mind when we were designing these processes, it has certainly paid off as our accounting, FP&A, tax and treasury teams amongst many others have done a tremendous job keeping our organization functioning at a very high level while working from home. On the corporate overhead front, we've lowered our expectations for full year G&A to between $125 million to $130 million versus our prior guidance of $140 million. This reduction is being driven by expected reductions in management and incentive compensation, reduction in travel expenses and new hires and a minimization of all discretionary corporate spend. Lastly as announced in last night's earnings release, we have decided to reduce our quarterly dividend to 70% of our pre-COVID quarterly dividend levels, resulting in a $0.61 per share dividend declared last night. Given the uncertainty surrounding the short and long-term impact of COVID-19 in our business and the broader economy as a whole, we felt preserving liquidity by reducing our second quarter dividend to better match our near-term expectations of underlying cash flow was the most prudent way for us to maximize balance sheet stability as we navigate these unprecedented times. We expect to further evaluate our long-term dividend policy as the year progresses. And with that, I will hand the call over to Shankh.